Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Luminex Corporation    LMNX

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
12/05/2016 12/06/2016 12/07/2016 12/08/2016 12/09/2016 Date
19.72(c) 19.9(c) 19.14(c) 19.4(c) 19.89(c) Last
171 987 288 493 380 209 717 122 332 664 Volume
+1.13% +0.91% -3.82% +1.36% +2.53% Change
More quotes
Financials ($)
Sales 2016 269 M
EBIT 2016 30,9 M
Net income 2016 21,8 M
Debt 2016 89,0 M
Yield 2016 -
Sales 2017 294 M
EBIT 2017 29,3 M
Net income 2017 21,1 M
Debt 2017 117 M
Yield 2017 -
P/E ratio 2016 39,00
P/E ratio 2017 43,24
EV / Sales2016 3,56x
EV / Sales2017 3,35x
Capitalization 867 M
More Financials
Company
Luminex Corp. develops, manufactures and markets proprietary biological testing technologies and products with applications throughout the life sciences and diagnostics industries.Luminex was founded by Mark B. Chandler and Van S. Chandler in May 1995 and is headquartered in Austin, TX. 
More about the company
Surperformance© ratings of Luminex Corporation
Trading Rating : Investor Rating :
More Ratings
Latest news on LUMINEX CORPORATION
12/05 LUMINEX : ARIES System and Flu A/B & RSV Assay Evaluated by Erasmus MC in New Pu..
12/05 LUMINEX : wins R&D 100 Award for ARIES Systems
12/01 LUMINEX : Patent Issued for Particle Populations and Assays Having Varying Amoun..
11/22 LUMINEX : ARIES System and Flu A/B & RSV Assay Evaluated by Erasmus MC in New Pu..
11/21 LUMINEX : Project SSSHH Makes Noise In Motion Pictures With LUMINEX
11/07 LUMINEX : Reports Third Quarter 2016 Results; Raises Full Year Guidance
11/07 LUMINEX CORPORATION : To Present At The 28th Annual Piper Jaffray Healthcare Con..
11/07 LUMINEX : Jewel Nightclub Shines With Network Intelligence From Luminex
11/04 GLOBAL FLOW CYTOMETRY INSTRUMENTATIO : Beckman Coulter-Danaher, BD, Bio-Rad Labo..
11/01 LUMINEX : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULT..
More news
Sector news : Advanced Medical Equipment & Technology - NEC
12/08 AIXTRON : China's Fujian drops Aixtron bid after Obama blocks deal
12/05 Aixtron could revive takeover despite U.S. block
12/02 Deals scuppered by U.S. regulatory scrutiny
11/29 European spin-offs and carve-outs
11/15 EXCLUSIVE : EU regulators seen clearing $25 billion Abbott, St Jude deal
More sector news : Advanced Medical Equipment & Technology - NEC
News from SeekingAlpha
11/01 HEALTHCARE - TOP 5 GAINERS / LOSERS : 00 am
10/31 Luminex's (LMNX) CEO Homi Shamir on Q3 2016 Results - Earnings Call Transcrip..
10/31 After Hours Gainers / Losers
10/31 Luminex beats by $0.11, beats on revenue
10/30 Notable earnings after Monday?s close
Advertisement
Chart LUMINEX CORPORATION
Duration : Period :
Luminex Corporation Technical Analysis Chart | LMNX | US55027E1029 | 4-Traders
Full-screen chart
Technical analysis trends LUMINEX CORPORATION
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 7
Average target price 23,3 $
Spread / Average Target 17%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Nachum Shamir President, Chief Executive Officer & Director
G. Walter Loewenbaum Chairman
Harriss T. Currie Chief Financial Officer, Treasurer & SVP-Finance
Thomas J. Copa Vice President-Technology & Strategic Partnerships
Charles J. Collins Vice President-Systems Research & Development
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
LUMINEX CORPORATION-9.30%867
THERMO FISHER SCIENTIF..2.51%57 441
DANAHER CORPORATION9.50%54 022
BOSTON SCIENTIFIC CORP..11.77%28 336
PHILIPS18.95%28 064
INTUITIVE SURGICAL, IN..13.42%24 225
More Results